Inventor
POUPART MARC-ANDRE
CA34 patents
⚠️ This page may combine multiple inventors who share the name “POUPART MARC-ANDRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM CA LTD
16 patentsUS6534523B1Mar 18, 2003
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD236 citations99
US6410531B1Jun 25, 2002
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD220 citations99
US6329379B1Dec 11, 2001
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD86 citations99
US7141574B2Nov 28, 2006
Viral polymerase inhibitors
BOEHRINGER INGELHEIM CA LTD108 citations98
US6420380B2Jul 16, 2002
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD215 citations98
US6323180B1Nov 27, 2001
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD319 citations98
US6767991B1Jul 27, 2004
Hepatitis C inhibitor peptides
BOEHRINGER INGELHEIM CA LTD115 citations97
US6329417B1Dec 11, 2001
Hepatitis C inhibitor tri-pepitides
BOEHRINGER INGELHEIM CA LTD70 citations97
USRE40525ESep 30, 2008
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD40 citations96
US6143715ANov 7, 2000
Hepatitis C inhibitor peptide analogues
BOEHRINGER INGELHEIM CA LTD74 citations94
US7893084B2Feb 22, 2011
Viral polymerase inhibitors
BOEHRINGER INGELHEIM CA LTD23 citations92
US7157486B2Jan 2, 2007
Viral polymerase inhibitors
BOEHRINGER INGELHEIM CA LTD29 citations92
US7576079B2Aug 18, 2009
Viral polymerase inhibitors
BOEHRINGER INGELHEIM CA LTD4 citations73
USRE42164EFeb 22, 2011
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
USRE41894EOct 26, 2010
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
USRE41356EMay 25, 2010
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
BOEHRINGER INGELHEIM INT
11 patentsUS7323470B2Jan 29, 2008
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT16 citations92
US7098231B2Aug 29, 2006
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT37 citations92
US7223785B2May 29, 2007
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT42 citations91
US7386398B2Jun 10, 2008
Hepatitis C Virus NS5B polymerase inhibitor binding pocket
BOEHRINGER INGELHEIM INT20 citations90
US7511157B2Mar 31, 2009
Hepatitis C inhibitor dipeptide analogs
BOEHRINGER INGELHEIM INT15 citations84
US7803944B2Sep 28, 2010
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT1 citations62
US7705146B2Apr 27, 2010
Hepatitis C inhibitor peptide analogs
BOEHRINGER INGELHEIM INT7 citations62
US7838537B2Nov 23, 2010
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT0 citations52
US7696242B2Apr 13, 2010
Hepatitis C inhibitor peptide analogs
BOEHRINGER INGELHEIM INT2 citations52
US7888363B2Feb 15, 2011
Viral polymerase inhibitors
BOEHRINGER INGELHEIM INT0 citations51
US7767818B2Aug 3, 2010
Hepatitis C inhibitor dipeptide analogs
BOEHRINGER INGELHEIM INT1 citations51
BIO MEGA BOEHRINGER INGELHEIM
3 patentsUS5554634ASep 10, 1996
N-(hydroxyethyl)butanediamide derivatives
BIO MEGA BOEHRINGER INGELHEIM4 citations58
US5523315AJun 4, 1996
N-(hydroxyethyl)butanediamide derivatives
BIO MEGA BOEHRINGER INGELHEIM1 citations58
US5565476AOct 15, 1996
N-(hydroxyethyl)butanediamide derivatives
BIO MEGA BOEHRINGER INGELHEIM0 citations48